FX Solutions Receives FDA 510k Clearances for Glenoid Baseplate With a Central Screw and 32mm Glenosphere and Humeral Cups

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

The Glenoid Baseplate includes a Central Screw that has (7) different central screw size length options ranging from 8mm to 20mm in 2mm increments. This provides an alternative to the glenoid baseplate having a central post and post extensions that FX currently has available to the US market. The addition of the glenoid baseplate with a central screw allows surgeons perioperative options to address a variety of deficiencies and can now accommodate an even larger patient population and surgeon’s needs.

The 32mm Glenosphere and Humeral Cups further expand the offerings that FX has available to the US market, which includes the existing sizes of 36mm and 40mm. With the 32mm components added to the FX portfolio, surgeons may be able to address more diverse patient needs.

“These are significant achievements and additions for our portfolio. There is a constant need and request for exactly these types of implants. They complement what we already have and, even more so, allows us to further compete in an extremely competitive market,” said Baptiste Martin, CEO of FX Shoulder USA. “These additions continue our adventure…” he continued to say.

To see the entire FX portfolio, you can visit their exhibit booth at AAOS in Orlando from March 25-27, 2020.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.